120 results
Page 4 of 6
6-K
EX-99.1
stc56t6rj1 1ny68s
13 Nov 19
Current report (foreign)
7:55am
6-K
EX-99.1
t7f5yz7c6fn
14 Aug 19
Current report (foreign)
12:00am
F-3
fzkmtmun
7 Aug 19
Shelf registration (foreign)
12:00am
6-K
EX-99.1
79xnh6
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
POS AM
bftzygm
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm
6-K
EX-99.1
rqgyydviyb71d6
14 Feb 19
At Market Issuance Sales Agreement
8:13am
424B5
cche iq54
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
EX-99.1
hzmisz
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.1
nic75ceu0d
14 Nov 18
Current report (foreign)
7:00am
POS AM
c9u0topyllmpq66k
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
6-K
EX-99.1
dqskpeehz65g155l3l
9 Oct 18
Current report (foreign)
5:21pm
424B5
038aufz1vmc9t16z98
5 Oct 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
dxiiqb7
4 Oct 18
Acasti Pharma Prices C$24 Million Underwritten Offering
11:00am
6-K
EX-99.1
wcwyk2xfw65
3 Oct 18
Acasti Pharma Announces Public Equity Offering
5:15pm
424B5
4yy47lln14g
3 Oct 18
Prospectus supplement for primary offering
4:51pm
6-K
EX-99.1
xd611s
14 Aug 18
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2019
1:04pm
6-K
EX-99.1
5ny4gxckwc8k8b8raq
14 Aug 18
Current report (foreign)
7:00am
6-K
EX-99.2
rje6rm22ku se
1 Aug 18
Notice of Annual and Special Meeting of Shareholders
12:00am